Cardiac Marker Testing Market
In addition , estimation of cardiac marker levels in the labs requires considerable time ; thus , it cannot be used in the determination of myocardial infarction during the acute phase further restraining its use .
Global Cardiac Marker Testing Market : Segmentation The global market for cardiac marker testing can be segmented based on disease , type of testing , product , type , and region . The disease segment of the market is divided into congestive heart failure and myocardial infarction . The type of testing segment of the market is diversified into point-of-care testing and laboratory testing . The product segment of the cardiac marker testing market is classified into immunofluorescence , immunochromatography , instruments , reagents and kits , chemiluminescence , and enzymelinked immunosorbent assay . The type segment of the market is divided into C-reactive protein , troponin I and T , brain natriuretic peptide or NT-proBNP , CK-MB , other biomarkers , and myoglobin . The other biomarkers segment of the market is classified into H-FABP , homocysteine , myeloperoxidase , galectin-3 , and ischemia-modified albumin . Regionally , the cardiac marker testing market is diversified into North America , Europe , Asia-Pacific , Latin America , and the Middle East & Africa .
Request Report TOC ( Table of Contents ) @ https :// www . zionmarketresearch . com / toc / cardiac-marker-testing-market
Global Cardiac Marker Testing Market : Regional Analysis North America is anticipated to dominate the global market of cardiac markers testing . The various factors contributing to the growth of the market in this region include rising aging population , increasing inclination toward point-of-care testing , and elevated frequency of cardiovascular disorders . Asia-Pacific region is also expected to grow in the global market in